Search
for
Sort by
Research 271–300 of 283
- The Important Role of Leptin in Modulating the Risk of Dermatological Diseases
- Dermatologische Probleme bei Kindern mit Adipositas
- Topical and transdermal lipid-polymer hybrid nanoparticles (LPN): an integration in advancing dermatological treatments
- Diagnosis, Pathogenesis and Management of Polycystic Ovary Syndrome
- 567 Acute generalized exanthematous pustulosis (AGEP) induced by plaquenil
- Human Regulatory T Cells: Understanding the Role of Tregs in Select Autoimmune Skin Diseases and Post-Transplant Nonmelanoma Skin Cancers
- Tyrosine kinase Inhibitors in Dermatology: A Systemic Review
- Immunopharmacological potential of Arctium lappa L. in immune-mediated skin diseases: A critical review of experimental and clinical evidence
- Metabolic pathways of eicosanoids—derivatives of arachidonic acid and their significance in skin
- Zinc, Copper, and Iron in Selected Skin Diseases
- Lifestyle interventions in dermatology
- Relationship between the level of vitamin D in bloof flow and skin dermatosis
- Author Index
- Alopecia areata as an immune-related adverse event associated with response to immune checkpoint inhibitors
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy
- 176 Myeloid cell-specific deletion of mTOR suppresses psoriasis-like skin inflammation in C57BL/6 mice
- Phosphodiesterase (PDE) Inhibitors for the Treatment of Inflammatory Skin Conditions
- Holistic Ayurvedic Management of Psoriasis with special reference to Eka Kustha
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy
- EFFECTIVENESS OF BAKUCHI (PSORALEA CORYLIFOLIA LINN.) AS RASAYANA THERAPY IN PSORIASIS - A CASE REPORT
- Ixekizumab shows efficacy and safety in patients who failed biweekly etanercept therapy: Analysis From UNCOVER-2, a phase 3 randomized clinical trial in psoriasis
- Efficacy and safety of topical rosuvastatin & melatonin vs. placebo in patients with mild to moderate plaque psoriasis: A preliminary randomized double‐blinded clinical trial
- Dovobet ointment under occlusion overnight for troublesome scalp psoriasis
- Dermpath & Clinic: Telangiectasia macularis eruptiva perstans
- 128 Bimekizumab led to rapid & deep normalisation of molecular signatures associated with PASI sub-components, preceding clinical skin clearance
- 151 High effectiveness of tildrakizumab over 52 weeks in patients with or without nail psoriasis: results from the phase IV POSITIVE Austrian subset
- Impact of ustekinumab on quality of life and sexual difficulties associated with psoriasis: Results from phase III clinical trials
- Fluticasone Propionate-loaded Black Cumin Oil NLCs with Dual Deposition/Permeation Capabilities for Enhanced Psoriasis Management
- MANAGEMENT OF EKAKUSTHA (PLAQUE PSORIASIS) THROUGH INTEGRATED SHODHANA AND SHAMANA CHIKITSA: A SINGLE CASE STUDY
- MANAGEMENT OF EKAKUSTHA (PLAQUE PSORIASIS) THROUGH INTEGRATED SHODHANA AND SHAMANA CHIKITSA: A SINGLE CASE STUDY